| Identity | Confirm that the material is beta-arbutin rather than alpha-arbutin, hydroquinone, or another brightening ingredient. | Product name: Beta-Arbutin
CAS No.: 497-76-7
INCI name: Arbutin
Common chemical name: 4-Hydroxyphenyl β-D-glucopyranoside | CAS number, chemical name, chromatographic identity, and supplier documentation should be consistent. Use a qualified laboratory for independent confirmation when the material is new or high risk. | Required |
| Basic Chemical Profile | Check whether the declared chemical profile matches beta-arbutin. | Molecular formula: C12H16O7
Molecular weight: approximately 272.25 g/mol | The formula and molecular weight should agree across the specification, certificate of analysis, safety data sheet, and technical data sheet. | Required |
| Appearance | Inspect color, crystal form, visible particles, and foreign matter. | Beta-arbutin is commonly supplied as a white to off-white crystalline powder. | Define a visual standard in the purchase specification. Reject material with unusual darkening, wet lumps, foreign particles, or evidence of contamination. | Required |
| Assay / Purity | Verify the concentration of beta-arbutin using a validated quantitative method. | High-purity cosmetic raw materials are commonly purchased against an assay specification such as not less than 98.0% or 99.0%, depending on the intended use and supplier capability. | Do not accept a generic “high purity” claim. The exact assay method, result, test date, batch number, and specification limit should appear on the COA. | Required |
| Related Substances | Control degradation products, process impurities, and structurally related substances. | Request an HPLC chromatogram or impurity profile. Hydroquinone should be specifically considered because it is chemically related to arbutin and is subject to different regulatory treatment. | Set individual and total impurity limits before purchase. A chromatogram without peak identification or acceptance criteria is insufficient for full qualification. | Required |
| Hydroquinone Control | Determine whether hydroquinone is absent or below the applicable analytical and legal limit. | Hydroquinone is not interchangeable with beta-arbutin. It may be restricted or prohibited in cosmetic products depending on the market and product type. | Request a specific hydroquinone test with a stated detection or quantification limit. Confirm the result against the destination-market requirement. | Required |
| Water Content | Measure moisture because excess water can affect stability, handling, and microbial risk. | Use Karl Fischer titration or another validated method. The acceptable limit must be defined in the agreed raw-material specification. | Compare the result with the supplier’s approved limit and trend results across batches. Abnormal moisture may indicate poor drying or improper storage. | Recommended |
| Solubility and pH | Check application-relevant dissolution behavior and solution pH. | Beta-arbutin is water-soluble. Solubility and pH results depend on concentration, temperature, water quality, and test procedure. | Specify the test concentration, solvent, temperature, equilibration time, and pH method. Avoid comparing results generated under different test conditions. | Recommended |
| Particle Characteristics | Review particle-size distribution, flowability, and tendency to agglomerate. | Particle size is normally a customer-specific quality attribute rather than a universal identity requirement. | Define a target range if the powder will be used in dry blending, encapsulation, or automated dosing. Confirm that the sampling method represents the whole batch. | Recommended |
| Microbiological Quality | Test total microbial counts and specified objectionable microorganisms. | Request total aerobic microbial count, total yeast and mold count, and relevant absence tests such as specified pathogens required by the product risk assessment. | Use limits appropriate for the finished cosmetic category and applicable standard. Low water activity does not eliminate the need for microbiological control. | Required |
| Heavy Metals and Elemental Impurities | Assess contamination from raw materials, processing equipment, water, and packaging. | Request an ICP-MS or equivalent report covering elements relevant to the raw material and destination market, such as lead, arsenic, mercury, and cadmium. | Use market-specific limits and a documented risk assessment. Do not rely on a statement that the product is “heavy-metal free” without numerical results or a defined detection limit. | Required |
| Residual Solvents | Identify solvents used during manufacture and confirm their control. | Request a residual-solvent declaration or analytical test covering process solvents. The test approach should be suitable for the solvents used. | Evaluate results against the applicable cosmetic, food, pharmaceutical, or internal toxicological limits, depending on the product category. | Recommended |
| Stability and Degradation | Evaluate discoloration, assay loss, impurity formation, and performance during storage. | Request available accelerated and real-time stability data, including assay, appearance, moisture, and related substances. | Confirm recommended storage conditions, retest or expiry period, packaging configuration, and evidence that the data represent the same grade being offered. | Required |
| Packaging | Check protection from moisture, light, oxygen, and contamination. | Review inner liner material, outer container, seal integrity, tamper evidence, net weight, lot code, and storage instructions. | Packaging should be clean, intact, appropriately closed, and compatible with the powder. Confirm whether the container has been opened or repacked. | Required |
| Certificate of Analysis | Confirm that the COA is batch-specific and traceable. | A complete COA should include product name, batch number, manufacturing date, retest or expiry date, test methods, results, specification limits, and authorized approval. | Match the COA batch number to the label and shipping documents. Generic or undated COAs should not be used as the sole release evidence. | Required |
| Safety Data Sheet | Review hazard classification, handling, storage, and transport information. | The SDS should follow the format required in the destination market and identify the substance correctly, including CAS number and relevant hazard information. | Check revision date, emergency information, exposure controls, PPE guidance, and whether the SDS matches the exact material supplied. | Required |
| Manufacturing Quality System | Assess production controls and batch-to-batch consistency. | Review quality certifications, audit reports, change-control procedures, deviation handling, complaint records, and traceability practices where available. | Prefer documented cosmetic or chemical manufacturing controls appropriate to the intended use. Certification alone does not replace raw-material testing. | Recommended |
| Regulatory Status | Verify whether beta-arbutin is permitted for the intended product, concentration, function, and market. | Check current official cosmetic legislation, restricted-substance lists, prohibited-substance lists, cosmetic ingredient inventories, and local notification or registration requirements. | Regulatory status is jurisdiction-specific and can change. Review the finished formula, product category, claims, labeling, and maximum use concentration—not only the raw material. | Required |
| EU Compliance Review | Determine whether the finished product meets European cosmetic requirements if placed on the EU market. | Review the current EU Cosmetics Regulation, Annex restrictions, Cosmetic Product Safety Report, Product Information File, responsible-person requirements, and CPNP notification obligations. | Do not assume that a raw material is automatically compliant because it is sold for cosmetic use. The final formula and claim substantiation must be assessed separately. | Market-Specific |
| United States Compliance Review | Assess compliance for products marketed in the United States. | Review the U.S. cosmetics framework, ingredient safety responsibility, facility and product obligations, labeling rules, and any requirements applicable to the product’s claims. | A cosmetic claim that implies treatment, disease prevention, or drug action may change the regulatory status of the finished product. | Market-Specific |
| Claims and Labeling | Ensure marketing claims do not exceed the available safety and performance evidence. | Claims such as “skin brightening,” “tone-evening,” or “reduces the appearance of dark spots” require appropriate substantiation and compliant wording in the destination market. | Use the INCI name “Arbutin” where required by the applicable labeling system, and verify declaration rules, concentration disclosure rules, and language requirements. | Required |
| Sample Qualification | Test a representative sample before approving a commercial order. | Compare appearance, identity, assay, impurities, moisture, microbiology, and other critical attributes against the approved specification. | Use a documented sampling plan. For a new source, consider testing multiple lots before moving to routine reduced testing. | Required |
| Final Supplier Decision | Score technical quality, compliance risk, documentation, supply continuity, and total cost. | Use a weighted supplier scorecard rather than price alone. Maintain approved-supplier status, periodic review, and change notification requirements. | Approve only when critical quality and regulatory documents are complete, test results meet specifications, and the intended use is legally acceptable in each target market. | Required |
